Anjuli Nayak

Summary

Publications

  1. ncbi Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis
    Anjuli S Nayak
    Sneeze, Wheeze and Itch Associates, LLC, Normal, IL 61761, USA
    Allergy Asthma Proc 33:404-10. 2012
  2. ncbi A review of montelukast in the treatment of asthma and allergic rhinitis
    Anjuli Nayak
    Department of Pediatrics, University of Illinois College of Medicine, Peoria, Illinois 61603, USA
    Expert Opin Pharmacother 5:679-86. 2004
  3. ncbi Mometasone furoate monohydrate nasal spray for the treatment of nasal congestion in allergic rhinitis
    Anjuli S Nayak
    Sneeze, Wheeze and Itch Associates, 2010 Jacobssen Drive, Normal, IL 61761, USA
    Expert Rev Clin Immunol 4:143-55. 2008
  4. ncbi Montelukast in the treatment of allergic rhinitis: an evidence-based review
    Anjuli Nayak
    Sneeze, Wheeze and Itch Associates, Normal, Illinois 61761, USA
    Drugs 67:887-901. 2007
  5. ncbi Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis
    Anjuli Nayak
    Sneeze, Wheeze and Itch Associates, 2010 Jacobssen Drive, Normal, IL 61761, USA
    Allergy Asthma Proc 24:323-9. 2003
  6. ncbi Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study
    Anjuli Nayak
    Pediatrics Department, Peoria School of Medicine, University of Illinois, 1300 Franklin Avenue 180, Normal, IL 61761, USA
    Chest 122:1956-65. 2002
  7. ncbi Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies
    Paul Chervinsky
    New England Research Center, North Dartmouth, Massachusetts, USA
    Ann Allergy Asthma Immunol 92:367-73. 2004
  8. ncbi The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma
    William W Busse
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, J5 219 CSC, Box 2454, 600 Highland Ave, Madison, WI 53792, USA
    J Allergy Clin Immunol 121:1167-74. 2008
  9. ncbi Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma
    Jill P Karpel
    North Shore University Hospital, New Hyde Park, NY 11040, USA
    Respir Med 101:628-37. 2007
  10. ncbi Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis
    Paul Chervinsky
    Northeast Medical Research Associates, 49 State Road, Suite 203, North Dartmouth, MA 02747, USA
    Allergy Asthma Proc 26:391-6. 2005

Detail Information

Publications11

  1. ncbi Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis
    Anjuli S Nayak
    Sneeze, Wheeze and Itch Associates, LLC, Normal, IL 61761, USA
    Allergy Asthma Proc 33:404-10. 2012
    ..Of tested doses, ragweed AIT 24 <Amb a 1-U once-daily was well tolerated in subjects with ragweed-induced ARC. Clinical trial registration URL and registration number: www.clinicaltrials.gov/ct2/show/NCT01134705 [corrected]...
  2. ncbi A review of montelukast in the treatment of asthma and allergic rhinitis
    Anjuli Nayak
    Department of Pediatrics, University of Illinois College of Medicine, Peoria, Illinois 61603, USA
    Expert Opin Pharmacother 5:679-86. 2004
    ..Clinical trials have shown that montelukast is effective and safe in the treatment of patients with asthma, allergic rhinitis or both diseases...
  3. ncbi Mometasone furoate monohydrate nasal spray for the treatment of nasal congestion in allergic rhinitis
    Anjuli S Nayak
    Sneeze, Wheeze and Itch Associates, 2010 Jacobssen Drive, Normal, IL 61761, USA
    Expert Rev Clin Immunol 4:143-55. 2008
    ..Numerous clinical trials have demonstrated that mometasone furoate nasal spray effectively relieves nasal congestion in adults and children with AR, while providing excellent safety and tolerability...
  4. ncbi Montelukast in the treatment of allergic rhinitis: an evidence-based review
    Anjuli Nayak
    Sneeze, Wheeze and Itch Associates, Normal, Illinois 61761, USA
    Drugs 67:887-901. 2007
    ..Montelukast provides an effective and well tolerated oral treatment for allergic airway inflammation in patients with SAR or PAR without asthma, and in patients in whom AR is comorbid with asthma...
  5. ncbi Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis
    Anjuli Nayak
    Sneeze, Wheeze and Itch Associates, 2010 Jacobssen Drive, Normal, IL 61761, USA
    Allergy Asthma Proc 24:323-9. 2003
    ..In summary, retreatment during a second pollen season with omalizumab, 300 mg every 3 or 4 weeks, was well tolerated and was not associated with any significant immunologic reactions...
  6. ncbi Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study
    Anjuli Nayak
    Pediatrics Department, Peoria School of Medicine, University of Illinois, 1300 Franklin Avenue 180, Normal, IL 61761, USA
    Chest 122:1956-65. 2002
    ..The clinical efficacy of HFA-BDP has been established in adult asthma at a required dose below that of CFC-BDP, but has not been evaluated in children...
  7. ncbi Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies
    Paul Chervinsky
    New England Research Center, North Dartmouth, Massachusetts, USA
    Ann Allergy Asthma Immunol 92:367-73. 2004
    ..CONCLUSIONS: Montelukast significantly improved daytime nasal symptoms score in patients with seasonal allergic rhinitis, and the effect was greater in patients exposed to higher pollen levels...
  8. ncbi The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma
    William W Busse
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, J5 219 CSC, Box 2454, 600 Highland Ave, Madison, WI 53792, USA
    J Allergy Clin Immunol 121:1167-74. 2008
    ....
  9. ncbi Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma
    Jill P Karpel
    North Shore University Hospital, New Hyde Park, NY 11040, USA
    Respir Med 101:628-37. 2007
    ..The reduction of oral prednisone use by mometasone furoate (MF) delivered by HFA-227 metered dose inhaler (MDI) was examined in oral corticosteroid (OCS)-dependent patients with severe persistent asthma...
  10. ncbi Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis
    Paul Chervinsky
    Northeast Medical Research Associates, 49 State Road, Suite 203, North Dartmouth, MA 02747, USA
    Allergy Asthma Proc 26:391-6. 2005
    ..therapy was more effective in reducing total symptom scores of SAR, including nasal congestion, than were the individual components. These results support the use of this combination therapy over desloratadine or pseudoephedrine alone...
  11. ncbi Omalizumab improves asthma-related quality of life in children with allergic asthma
    Robert F Lemanske
    University of Wisconsin, Madison, Wisconsin 53792, USA
    Pediatrics 110:e55. 2002
    ..Here we report the effects of treatment with omalizumab on asthma-related quality of life (AQoL) in children with allergic asthma...